Clinical Trials Directory

Trials / Unknown

UnknownNCT03977350

Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)

A Blind, Observational, Prospective, Multi -Center, One Arm, Study on the Association Between qEEG Measure and Post-Operative Cognitive Dysfunction (POCD) and Postoperative Delirium (POD)

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Neuroindex Ltd. · Industry
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Cognitive complications after major surgery are a common phenomenon. The incidence of Postoperative Cognitive Dysfunction (POCD), may vary from 5% to 25% in adult patients, depending on different risk factors. Age has been strongly associated with cognitive complications. POCD is a prolonged decline in cognitive function that appears after surgery as compared with preoperative functions. In order to classify evaluate POCD, it requires at least 2 measurements. A baseline, completed before surgery and a second measurement, post surgery. In light of the high prevalence of POCD and the difficulties in its prediction, NeuroIndex has developed a quantitative EEG system and software that aim to produces risk predictor index (IS) for POCD. This study aims to evaluate the relationship between the software produced predictor index and the actual POCD events. The qEEG will be monitored during the surgery in addition to the routine clinical practice in operating rooms. POCD will be evaluated using Montreal Cognitive Assessment test (MoCA) prior and post surgery.

Conditions

Interventions

TypeNameDescription
DEVICEEEG monitoringEEG monitoring under general anesthesia

Timeline

Start date
2019-09-23
Primary completion
2021-09-01
Completion
2022-12-01
First posted
2019-06-06
Last updated
2020-09-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03977350. Inclusion in this directory is not an endorsement.